Pfizer vaccine reduces Covid-19 death by 94% – Discovery Health study
Discovery Health has released “unequivocal” evidence showing that those who have received a Pfizer vaccine have a 94% reduced risk of dying from Covid-19 complications two weeks after the second dose. The company, which has had more than 60% of its adult members vaccinated against Covid-19, shared the results from the study on Monday.
CEO of Discovery Health, Dr Ryan Noach, said the company’s actuarial team collaborated with leading scientists and clinicians for the study.“The evidence is unequivocal: vaccines work; are incredibly safe and reduce individual risk and represent the most reliable route to fast-tracking our return to normality,” he said.
“The country needs to move faster if we want to return to pre-Covid-19 life. Covid-19 vaccine hesitancy is a key deterrent to vaccine uptake and is fuelled in large part by misinformation, which drives confusion and fear,” he said. Scientists and researchers determined the Pfizer vaccine’s effectiveness by analysing 526 516 pathology test results, 14 673 Covid-19 admissions and 3 441 Covid‑19 deaths, all between May and September 2021.
- The Pfizer vaccine reduces the risk of admission to hospital following a Covid-19 infection by 92%, 14 days or more after receiving the second dose.
- Reduces the risk of Covid-19 infection by 79%, 14 days or more after receiving the second dose.
- Reduces the risk of being admitted to hospital for another Covid-19 infection by 98%, for those who have recovered from a Covid-19 infection, and are vaccinated on top of this.
By Kelly Jane Turner and originally appeared in the Independent Online